首页> 外文期刊>Journal of psychopharmacology >The development of a clinical syndrome of asymptomatic pancreatitis and eosinophilia after treatment with clozapine in schizophrenia: implications for clinical care, recognition and management.
【24h】

The development of a clinical syndrome of asymptomatic pancreatitis and eosinophilia after treatment with clozapine in schizophrenia: implications for clinical care, recognition and management.

机译:氯氮平治疗精神分裂症后无症状胰腺炎和嗜酸性粒细胞增多的临床综合征的发展:对临床护理,识别和管理的意义。

获取原文
获取原文并翻译 | 示例
           

摘要

Clozapine, the first atypical antipsychotic, is indicated for the treatment of therapy-resistant schizophrenia. It needs to be monitored closely because of its well-known potential side-effects, especially agranulocytosis. We present a case of a middle-aged woman with chronic schizophrenia, who was treated with clozapine and developed a clinical syndrome of asymptomatic pancreatitis and eosinophilia within the fifth week of treatment. Asymptomatic pancreatitis has rarely been reported up to now and is not recognized as a typical side-effect of clozapine. In our opinion, pancreatic enzymes should be monitored especially in the first 6 weeks of clozapine treatment.
机译:氯氮平是第一种非典型的抗精神病药,可用于治疗难治性精神分裂症。由于其众所周知的潜在副作用,尤其是粒细胞缺乏症,需要对其进行密切监测。我们介绍了一个患有慢性精神分裂症的中年妇女的病例,该妇女接受氯氮平治疗,在治疗的第五周内出现了无症状性胰腺炎和嗜酸性粒细胞增多的临床综合征。迄今为止,无症状胰腺炎鲜有报道,尚未被视为氯氮平的典型副作用。我们认为,应特别在氯氮平治疗的前6周监测胰腺酶。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号